<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>34(6)</volume><submitter>Li ST</submitter><funding>American Cancer Society</funding><funding>NHLBI NIH HHS</funding><journal>Leukemia</journal><pagination>1675-1678</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8908771</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Rare germline variant contributions to myeloid malignancy susceptibility.</pubmed_title><pmcid>PMC8908771</pmcid><funding_grant_id>123436-RSG-12-159-01-DMC</funding_grant_id><funding_grant_id>R35 HL135795</funding_grant_id><pubmed_authors>Kuzmanovic T</pubmed_authors><pubmed_authors>Wei R</pubmed_authors><pubmed_authors>Shi R</pubmed_authors><pubmed_authors>Adema V</pubmed_authors><pubmed_authors>Kerr CM</pubmed_authors><pubmed_authors>Sole F</pubmed_authors><pubmed_authors>Li ST</pubmed_authors><pubmed_authors>Nagata Y</pubmed_authors><pubmed_authors>Przychodzen B</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Maciejewski JP</pubmed_authors><pubmed_authors>LaFramboise T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rare germline variant contributions to myeloid malignancy susceptibility.</name><description/><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-04T23:16:53.859Z</modification><creation>2025-04-04T23:16:53.859Z</creation></dates><accession>S-EPMC8908771</accession><cross_references><pubmed>31911633</pubmed><doi>10.1038/s41375-019-0701-8</doi></cross_references></HashMap>